A type of rare T cell triggers a cascade of signals amplifying inflammation and ultimately leading to liver fibrosis, according to a new study from Julius Maximilian University of Würzburg published in Nature Communications. Over time, this process contributes to a sustained decline in liver function.
Continue Reading this article here
